{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:24:48Z","timestamp":1795029888066,"version":"4.10.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014578","name":"Finnish Institute for Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005415","name":"University of Iceland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lanepe.2024.100849","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T23:38:06Z","timestamp":1707435486000},"page":"100849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-6435","authenticated-orcid":false,"given":"Jakob","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0761-9028","authenticated-orcid":false,"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-4749","authenticated-orcid":false,"given":"Maarit K.","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-5102","authenticated-orcid":false,"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-7525","authenticated-orcid":false,"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-0978","authenticated-orcid":false,"given":"Jannicke","family":"Igland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-0503","authenticated-orcid":false,"given":"Yuelian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-5352","authenticated-orcid":false,"given":"Torbj\u00f6rn","family":"Tomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-8109","authenticated-orcid":false,"given":"Silje","family":"Alvestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-1094","authenticated-orcid":false,"given":"Marte-Helene","family":"Bj\u00f8rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-4170","authenticated-orcid":false,"given":"Julie Werenberg","family":"Dreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8663","key":"10.1016\/j.lanepe.2024.100849_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","article-title":"Weight in infancy and death from ischaemic heart disease","volume":"2","author":"Barker","year":"1989","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lanepe.2024.100849_bib2","article-title":"Low birth weight increases the risk of sudden cardiac death in the young: a nationwide study of 2.2 million people","volume":"10","author":"Waaler Loland","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.lanepe.2024.100849_bib3","first-page":"1","article-title":"Antiseizure medication use during pregnancy and neonatal growth outcomes: a systematic review and meta-analysis","author":"Lavu","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lanepe.2024.100849_bib4","series-title":"Antiepileptic drugs: review of safety of use during pregnancy","author":"The Medicines and Healthcare products Regulatory Agency","year":"2021"},{"issue":"11","key":"10.1016\/j.lanepe.2024.100849_bib5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/epi.12758","article-title":"Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study","volume":"55","author":"Kilic","year":"2014","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.lanepe.2024.100849_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.seizure.2009.09.002","article-title":"Population-based study of antiepileptic drug exposure in utero--influence on head circumference in newborns","volume":"18","author":"Almgren","year":"2009","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.lanepe.2024.100849_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1528-1157.2000.tb00253.x","article-title":"Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years","volume":"41","author":"Wide","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100849_bib8","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1212\/WNL.0000000000007696","article-title":"Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs","volume":"93","author":"Bloti\u00e8re","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.lanepe.2024.100849_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214180","article-title":"Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth","volume":"14","author":"Margulis","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lanepe.2024.100849_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","article-title":"Differential effects of antiepileptic drugs on neonatal outcomes","volume":"24","author":"Pennell","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.lanepe.2024.100849_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"L\u00f6scher","year":"2021","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100849_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/aian.AIAN_492_16","article-title":"Teratogenic effects of carbamazepine in mice","volume":"20","author":"Jose","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100849_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/tera.1420410308","article-title":"Teratogenicity of carbamazepine in rats","volume":"41","author":"Vorhees","year":"1990","journal-title":"Teratology"},{"key":"10.1016\/j.lanepe.2024.100849_bib14","series-title":"Oxcarbazepine prescribing information FDA","year":"2017"},{"key":"10.1016\/j.lanepe.2024.100849_bib15","series-title":"Clonazepam prescribing information FDA","year":"2021"},{"key":"10.1016\/j.lanepe.2024.100849_bib16","series-title":"Topiramate prescribing information FDA","year":"2012"},{"issue":"7","key":"10.1016\/j.lanepe.2024.100849_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100849_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","article-title":"The Nordic countries as a cohort for pharmacoepidemiological research","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.lanepe.2024.100849_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpeds.2017.12.059","article-title":"Consensus based definition of growth restriction in the newborn","volume":"196","author":"Beune","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"11","key":"10.1016\/j.lanepe.2024.100849_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bdra.23587","article-title":"Population-based microcephaly surveillance in the United States, 2009 to 2013: an analysis of potential sources of variation","volume":"106","author":"Cragan","year":"2016","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100849_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1467-9531.2009.01215.x","article-title":"8. How to impute interactions, squares, and other transformed variables","volume":"39","author":"von Hippel","year":"2009","journal-title":"Socio Methodol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100849_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.26561","article-title":"Comparative safety of antiseizure medication monotherapy for major malformations","volume":"93","author":"Cohen","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.100849_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.6065\/apem.2018.23.1.4","article-title":"Small for gestational age and obesity related comorbidities","volume":"23","author":"Hong","year":"2018","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.lanepe.2024.100849_bib24","series-title":"Carbamazepine prescribing information FDA","year":"2022"},{"issue":"5","key":"10.1016\/j.lanepe.2024.100849_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40264-013-0052-8","article-title":"Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland","volume":"36","author":"Artama","year":"2013","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.lanepe.2024.100849_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017248","article-title":"Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis","volume":"7","author":"Veroniki","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100849_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.25031","article-title":"Fetal growth and premature delivery in pregnant women on antiepileptic drugs","volume":"82","author":"Hern\u00e1ndez-D\u00edaz","year":"2017","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.lanepe.2024.100849_bib28","first-page":"579","article-title":"Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy","volume":"261","author":"Veiby","year":"2014","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100849_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/EDE.0000000000001562","article-title":"Emulating a target trial of interventions initiated during pregnancy with healthcare databases: the example of COVID-19 vaccination","volume":"34","author":"Hern\u00e1ndez-D\u00edaz","year":"2023","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100849_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A\u00a0United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.lanepe.2024.100849_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1542\/peds.2013-3285","article-title":"United States birth weight reference corrected for implausible gestational age estimates","volume":"133","author":"Talge","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.lanepe.2024.100849_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CLEP.S16305","article-title":"Drug use during pregnancy in Sweden\u2013assessed by the prescribed drug register and the medical birth register","volume":"3","author":"Stephansson","year":"2011","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.lanepe.2024.100849_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-003-0584-4","article-title":"Prescription drugs during pregnancy and lactation--a Finnish register-based study","volume":"59","author":"Malm","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.lanepe.2024.100849_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001648-200109000-00006","article-title":"Do pregnant women report use of dispensed medications?","volume":"12","author":"Olesen","year":"2001","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.lanepe.2024.100849_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of seizures during gestation on pregnancy outcomes in women with epilepsy","volume":"66","author":"Chen","year":"2009","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.lanepe.2024.100849_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.13202","article-title":"Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis","volume":"122","author":"Hodgetts","year":"2015","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.lanepe.2024.100849_bib37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaneurol.2022.2977","article-title":"Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy","volume":"79","author":"Vegrim","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.lanepe.2024.100849_bib38","first-page":"349","article-title":"Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study","author":"Bech","year":"2014","journal-title":"BMJ"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:39:11Z","timestamp":1716014351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"alternative-id":["S2666776224000152"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100849","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100849"}}